PCI-32765 (Ibrutinib)

PCI-32765 (Ibrutinib)

Catalog Number:
L002368460APE
Mfr. No.:
APE-A3001
Price:
$188
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          PCI-32765, also named as Ibrutinib, is a Bruton tyrosine kinase inhibitor which is used to study the biological effects of Bruton tyrosine kinase inhibition on mature B-cell function and the progression of B cell-associated diseases in vivo. The Bruton tyrosine kinase is specifically necessary for BCR signaling as demonstrated by human and mouse mutations that disrupt Bruton tyrosine kinase function and prevent B-cell maturation at steps which need a functional BCR pathway. PCI-32765 also inhibited autoantibody production. Occupancy of the Bruton tyrosine kinase active site by PCI-32765 was monitored in vitro and in vivo using a fluorescent affinity probe for Bruton tyrosine kinase.

      • Properties
        • Alternative Name
          PCI-32765,Ibrutinib,CRA-032765; 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
          CAS Number
          936563-96-1
          Molecular Formula
          C25H24N6O2
          Molecular Weight
          440.5
          Appearance
          A solid
          Purity
          99.72%
          Solubility
          ≥22.02 mg/mL in DMSO; insoluble in H2O; ≥10.4 mg/mL in EtOH with ultrasonic
          Storage
          Desiccate at -20°C

          * For Research Use Only

      • Reference
        • 1. Madison Barbara Allerton Hagger. "The Synergy of Adenosine and Ibrutinib on Platelet Aggregation in Chronic Lymphocytic Leukemia." Murdoch University 2021.
          2. Alhakeem SS, McKenna MK, et al. "Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity." J Immunol. 2018 Jun 15;200(12):4180-4189. PMID:29712773
          3. Schroeder JT, Bieneman AP. "Activation of Human Basophils by A549 Lung Epithelial Cells Reveals a Novel IgE-Dependent Response Independent of Allergen." J Immunol. 2017 Aug 1;199(3):855-865. PMID:28652400
          4. Kosowicz JG, Lee J, et al. "Drug modulators of B cell signaling pathways and Epstein-Barr virus lytic activation." J Virol. 2017 May 31. pii: JVI.00747-17. PMID:28566383
          5. Lee DD, Muskaj I, et al. "Platelet proteins cause basophil histamine release through an immunoglobulin-dependent mechanism. Transfusion." 2017 May 4. PMID:28470742

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.